Performance of different body weights in the Cockcroft-Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort.

IF 2.9 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Pharmacotherapy Pub Date : 2023-11-01 Epub Date: 2022-11-24 DOI:10.1002/phar.2743
Michaelia D Cucci, Anthony T Gerlach, Caroline Mangira, Claire V Murphy, Jason A Roberts, Andrew A Udy, Thomas C Dowling, Chanda L Mullen
{"title":"Performance of different body weights in the Cockcroft-Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort.","authors":"Michaelia D Cucci, Anthony T Gerlach, Caroline Mangira, Claire V Murphy, Jason A Roberts, Andrew A Udy, Thomas C Dowling, Chanda L Mullen","doi":"10.1002/phar.2743","DOIUrl":null,"url":null,"abstract":"<p><strong>Study objective: </strong>The primary objective was to evaluate the performance of the Cockcroft-Gault (CG) equation with different body weights (BWs) compared to a measured creatinine clearance (mCrCl) in an intensive care unit (ICU) population with and without augmented renal clearance (ARC).</p><p><strong>Design: </strong>Multicenter, retrospective cohort.</p><p><strong>Setting: </strong>Two ICUs in the United States and four ICUs from a previous international observational analysis.</p><p><strong>Patients: </strong>Adult ICU patients admitted from January 1, 2010 to July 30, 2020 with at least one mCrCl collected within the initial 10 days of hospitalization were eligible for inclusion.</p><p><strong>Measurements and main results: </strong>The primary outcome was the performance of the CG equation in ARC (mCrCl≥130 ml/min/1.73 m<sup>2</sup> ) and non-ARC (mCrCl<130 ml/min/1.73 m<sup>2</sup> ) patients. Correlation was analyzed by Pearson's correlation coefficient, bias by mean difference, and accuracy by the percentage of patients within 30% of the mCrCl. A total of 383 patients were included, which provided 1708 mCrCl values. The majority were male (n = 239, 62%), median age of 55 years [IQR 40-65] with a surgical diagnosis (n = 239, 77%). ARC was identified in 229 (60%) patients. The ARC group had lower Scr values (0.6 [0.5-0.7] vs. 0.7 [0.6-0.9] mg/dl, p < 0.001) and higher mCrCl (172.8 (SD 39.1) vs. 89.9 mL/min/1.73 m<sup>2</sup> (SD 25.4), p < 0.001) compared with the non-ARC group, respectively. Among non-ARC patients there was a moderate correlation (r = 0.33-0.39), moderate accuracy (range 48-58%), and low bias (range of -12.9 to 17.1) among the different BW estimations with the adjusted BW having the better performance. Among ARC patients there was low correlation (r = 0.24-0.28), low to moderate accuracy (range 38-70%), and high bias (range of -58.5 to -21.6).</p><p><strong>Conclusions: </strong>The CG-adjusted BW had the best performance in the non-ARC patients, while CG performed poorly with any BW in ARC patients. Although the CG equation remains the standard equation for estimating CrCl in the ICU setting, a new, validated equation is needed for patients with ARC.</p>","PeriodicalId":20013,"journal":{"name":"Pharmacotherapy","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10947228/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/phar.2743","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/11/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Study objective: The primary objective was to evaluate the performance of the Cockcroft-Gault (CG) equation with different body weights (BWs) compared to a measured creatinine clearance (mCrCl) in an intensive care unit (ICU) population with and without augmented renal clearance (ARC).

Design: Multicenter, retrospective cohort.

Setting: Two ICUs in the United States and four ICUs from a previous international observational analysis.

Patients: Adult ICU patients admitted from January 1, 2010 to July 30, 2020 with at least one mCrCl collected within the initial 10 days of hospitalization were eligible for inclusion.

Measurements and main results: The primary outcome was the performance of the CG equation in ARC (mCrCl≥130 ml/min/1.73 m2 ) and non-ARC (mCrCl<130 ml/min/1.73 m2 ) patients. Correlation was analyzed by Pearson's correlation coefficient, bias by mean difference, and accuracy by the percentage of patients within 30% of the mCrCl. A total of 383 patients were included, which provided 1708 mCrCl values. The majority were male (n = 239, 62%), median age of 55 years [IQR 40-65] with a surgical diagnosis (n = 239, 77%). ARC was identified in 229 (60%) patients. The ARC group had lower Scr values (0.6 [0.5-0.7] vs. 0.7 [0.6-0.9] mg/dl, p < 0.001) and higher mCrCl (172.8 (SD 39.1) vs. 89.9 mL/min/1.73 m2 (SD 25.4), p < 0.001) compared with the non-ARC group, respectively. Among non-ARC patients there was a moderate correlation (r = 0.33-0.39), moderate accuracy (range 48-58%), and low bias (range of -12.9 to 17.1) among the different BW estimations with the adjusted BW having the better performance. Among ARC patients there was low correlation (r = 0.24-0.28), low to moderate accuracy (range 38-70%), and high bias (range of -58.5 to -21.6).

Conclusions: The CG-adjusted BW had the best performance in the non-ARC patients, while CG performed poorly with any BW in ARC patients. Although the CG equation remains the standard equation for estimating CrCl in the ICU setting, a new, validated equation is needed for patients with ARC.

在有和没有增强肾清除率的危重患者中,不同体重在Cockcroft-Gault方程中的表现:一个多中心队列
研究目的:主要目的是评估在有和没有增强肾清除率(ARC)的重症监护病房(ICU)人群中,不同体重(BWs)的Cockcroft-Gault (CG)方程与测量肌酐清除率(mccrcl)的性能。设计:多中心,回顾性队列。环境:2个icu在美国,4个icu来自先前的国际观察分析。患者:2010年1月1日至2020年7月30日入住ICU的成人患者,在入院前10天内收集到至少一个mccrcl,符合纳入条件。测量和主要结果:主要结果是ARC (mCrCl≥130 ml/min/1.73 m2)和非ARC (mCrCl2)患者的CG方程的表现。相关性分析采用Pearson相关系数,偏倚分析采用均数差,准确性分析采用mCrCl在30%以内的患者百分比。共纳入383例患者,提供1708个mccrcl值。多数为男性(n = 239, 62%),中位年龄55岁[IQR 40-65],手术诊断(n = 239, 77%)。229例(60%)患者中发现了ARC。ARC组Scr值较低(0.6 [0.5-0.7]vs. 0.7 [0.6-0.9] mg/dl, p 2 (SD 25.4), p结论:CG调整后的体重在非ARC患者中表现最佳,而CG调整后的体重在ARC患者中表现较差。虽然CG方程仍然是估计ICU环境下CrCl的标准方程,但对于ARC患者需要一个新的、经过验证的方程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacotherapy
Pharmacotherapy 医学-药学
CiteScore
7.80
自引率
2.40%
发文量
93
审稿时长
4-8 weeks
期刊介绍: Pharmacotherapy is devoted to publication of original research articles on all aspects of human pharmacology and review articles on drugs and drug therapy. The Editors and Editorial Board invite original research reports on pharmacokinetic, bioavailability, and drug interaction studies, clinical trials, investigations of specific pharmacological properties of drugs, and related topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信